Description

PEG MGF Peptide Vials

Introduction

Peptide vials containing PEG MGF (Polyethylene Glycol Mechano Growth Factor) are a highly sought after product for researchers in various scientific fields. These vials offer exceptional characteristics, applications, and benefits that make them an invaluable tool in research contexts.

Key Characteristics

The product, PEG MGF Vials, comprises a PEGylated form of Mechano Growth Factor, ensuring high purity and stability to yield reliable research outcomes. It offers precise dosage presentation in vials, facilitating controlled experimentation, and is manufactured in adherence to rigorous research standards.

Research Applications

PEG MGF vials are used in diverse research areas such as regenerative medicine, musculoskeletal studies, and cardiovascular research. The encapsulated PEG MGF peptide allows for targeted investigations into its effects on specific biological processes.

Research Benefits

PEG MGF Peptide and Bone Repair

Studies suggest that PEG MGF may support bone repair and regeneration. The peptide’s interaction with growth factors could contribute to enhanced bone healing processes, making it a valuable subject for further investigation in orthopedic research.

PEG MGF Peptide and Heart Disease

Research has explored the potential cardiovascular benefits of PEG-MGF. Preliminary findings indicate that the peptide might have cardioprotective properties, making it a promising candidate for heart disease research.

PEG MGF Peptide and Stroke

PEG MGF may have neuroprotective effects, potentially offering benefits in stroke-related studies. Emerging research suggests that PEG MGF may have neuroprotective effects, making it relevant for stroke-related research. Investigations into the peptide’s impact on neural regeneration and recovery mechanisms are ongoing.

Disclaimer

This content is presented exclusively for educational purposes and should not be construed as medical advice. THE MATERIALS REFERENCED HEREIN ARE EXCLUSIVELY INTENDED FOR LABORATORY AND RESEARCH USE.

Any clinical research initiatives must be conducted under the guidance of the relevant Institutional Review Board (IRB). Similarly, preclinical research involving animals must comply with the directives of the Institutional Animal Care and Use Committee (IACUC), adhering to the standards delineated by the Animal Welfare Act (AWA).

Our informational content is meticulously designed for research-oriented insights and is not a substitute for individual analysis and verification from credible sources before any purchasing decisions are made.

Upon finalizing your order and payment, you explicitly acknowledge and agree to adhere to our Terms and Conditions. Customer satisfaction is our top priority. If you are dissatisfied with the product received, kindly contact us at 419-707-5450 or email our support team at support@bc9.co.

IMPORTANT NOTICE: All products showcased on our platform are EXCLUSIVELY INTENDED FOR LABORATORY AND RESEARCH APPLICATIONS. They are expressly not intended for veterinary or human utilization.

References

1. Jing X, Ye Y, Bao Y, Zhang J, Huang J, Wang R, Guo J, Guo F. Mechano-growth factor protects against mechanical overload-induced damage and promotes migration of growth plate chondrocytes through RhoA/YAP pathway. Exp Cell Res. 2018 May 15;366(2):81-91. doi: 10.1016/j.yexcr.2018.02.021. Epub 2018 Feb 20. PMID: 29470961. [Read More]
2. Doroudian G, Pinney J, Ayala P, Los T, Desai TA, Russell B. Sustained delivery of MGF peptide from microrods attracts stem cells and reduces apoptosis of myocytes. Biomed Microdevices. 2014 Oct;16(5):705-15. doi: 10.1007/s10544-014-9875-z. PMID: 24908137; PMCID: PMC4418932. [Read More]
3. Dluzniewska J, Sarnowska A, Beresewicz M, Johnson I, Srai SK, Ramesh B, Goldspink G, Górecki DC, Zabłocka B. A strong neuroprotective effect of the autonomous C-terminal peptide of IGF-1 Ec (MGF) in brain ischemia. FASEB J. 2005 Nov;19(13):1896-8. doi: 10.1096/fj.05-3786fje. Epub 2005 Sep 6. PMID: 16144956. [Read More]